Helicobacter pylori: when is treatment now indicated?
The prevalence of Helicobacter pylori in Western societies has rapidly declined, as reflected by the consistent decline in peptic ulcer disease. Nevertheless, there remains a cohort of the elderly population with a high prevalence of H. pylori infection. While the benefits of H. pylori eradication for H. pylori-associated duodenal ulcer disease is beyond dispute, a number of contentious areas remains. The aim of the present paper is to review the benefits of H. pylori eradication in clinical situations that may confront the non-gastroenterologist.
Duggan
A
A
Department of Gastroenterology, John Hunter Hospital, Newcastle, New South Wales, Australia. aduggan@hunter.health.nsw.gov.au
D004381:Duodenal Ulcer / Q000382:microbiology / Q000628:therapy; D005767:Gastrointestinal Diseases / Q000382:microbiology* / Q000628:therapy; D016481:Helicobacter Infections / Q000628:therapy*; D016480:Helicobacter pylori; D006801:Humans; D013274:Stomach Neoplasms / Q000382:microbiology / Q000628:therapy